Persistence of Hepatitis C RNA in Liver Allografts Is Associated with Histologic Progression Independent of Serologic Viral Clearance

Background. Hepatitis C virus (HCV) nondetectability in the liver may predict a sustained viral response (SVR) in patients with an end of treatment response. HCV RNA can be detected in liver tissue by in situ hybridization (ISH). Aim. To determine if HCV nondetectability in liver allografts by ISH c...

Full description

Saved in:
Bibliographic Details
Main Authors: M. Ghabril, R. C. Dickson, M. Krishna, R. Lloyd, J. Aranda-Michel, A. Keaveny, R. Satyanarayana, H. Bonatti
Format: Article
Language:English
Published: Wiley 2009-01-01
Series:Journal of Transplantation
Online Access:http://dx.doi.org/10.1155/2009/297528
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832566880920928256
author M. Ghabril
R. C. Dickson
M. Krishna
R. Lloyd
J. Aranda-Michel
A. Keaveny
R. Satyanarayana
H. Bonatti
author_facet M. Ghabril
R. C. Dickson
M. Krishna
R. Lloyd
J. Aranda-Michel
A. Keaveny
R. Satyanarayana
H. Bonatti
author_sort M. Ghabril
collection DOAJ
description Background. Hepatitis C virus (HCV) nondetectability in the liver may predict a sustained viral response (SVR) in patients with an end of treatment response. HCV RNA can be detected in liver tissue by in situ hybridization (ISH). Aim. To determine if HCV nondetectability in liver allografts by ISH can predict SVR in patients who cleared virus serologically on treatment. Methods. Twenty five patients with undetectable serum HCV on Interferon/Ribavirin therapy for HCV recurrence post liver transplant (LT) were studied. All had biopsies at 4 months post LT (baseline) and follow up with HCV ISH analysis performed. Results. 10 were ISH positive (group 1); 15 were ISH negative (group 2). Groups 1 and 2 had similar patient, donor, and viral characteristics at LT, as well as treatment duration at the time of the ISH assayed liver biopsy (13±16 versus 10±4 months P = .24). However, group 1 had longer total treatment duration (24±10 versus 14±5 months, P = .001). Eight (80%) group 1 and 9 (60%) group 2 patients achieved SVR. Mean grade and stage (modified Ishak score) were similar at 4 months, however, group 1 had higher grade (3±1.7 versus 1.6±1.3, P = .039) and stage (1.4±1.4 versus 0.5±0.6, P = .084) on the ISH assayed biopsy, after similar post LT intervals (23±10 versus 24±12 months, P = .91). Conclusion. Allograft HCV ISH nondetectability does not predict SVR in treatment responsive HCV recurrence, but is associated with less severe histologic disease.
format Article
id doaj-art-19c904959640487d92321d30b36be716
institution Kabale University
issn 2090-0007
2090-0015
language English
publishDate 2009-01-01
publisher Wiley
record_format Article
series Journal of Transplantation
spelling doaj-art-19c904959640487d92321d30b36be7162025-02-03T01:02:52ZengWileyJournal of Transplantation2090-00072090-00152009-01-01200910.1155/2009/297528297528Persistence of Hepatitis C RNA in Liver Allografts Is Associated with Histologic Progression Independent of Serologic Viral ClearanceM. Ghabril0R. C. Dickson1M. Krishna2R. Lloyd3J. Aranda-Michel4A. Keaveny5R. Satyanarayana6H. Bonatti7Department of Gastroenterology and Hepatology, Clarian/Indiana University School of Medicine, 975 W Walnut Street 1B327, Department of Gastroenterology and Hepatology, Mayo Clinic, 4500 San Pablo Road, Jacksonville, FL 32224, USADepartment of Pathology, Mayo Clinic, 4500 San Pablo Road, Jacksonville, FL 32224, USADepartment of Pathology, Mayo Clinic, 200 First Street SW, Rochester, MN 55902-3219, USADepartment of Gastroenterology and Hepatology, Mayo Clinic, 4500 San Pablo Road, Jacksonville, FL 32224, USADepartment of Gastroenterology and Hepatology, Mayo Clinic, 4500 San Pablo Road, Jacksonville, FL 32224, USADepartment of Gastroenterology and Hepatology, Mayo Clinic, 4500 San Pablo Road, Jacksonville, FL 32224, USADepartment of Surgery, University of Virginia, P.O. Box 800709 Charlottesville, VA 22906, USABackground. Hepatitis C virus (HCV) nondetectability in the liver may predict a sustained viral response (SVR) in patients with an end of treatment response. HCV RNA can be detected in liver tissue by in situ hybridization (ISH). Aim. To determine if HCV nondetectability in liver allografts by ISH can predict SVR in patients who cleared virus serologically on treatment. Methods. Twenty five patients with undetectable serum HCV on Interferon/Ribavirin therapy for HCV recurrence post liver transplant (LT) were studied. All had biopsies at 4 months post LT (baseline) and follow up with HCV ISH analysis performed. Results. 10 were ISH positive (group 1); 15 were ISH negative (group 2). Groups 1 and 2 had similar patient, donor, and viral characteristics at LT, as well as treatment duration at the time of the ISH assayed liver biopsy (13±16 versus 10±4 months P = .24). However, group 1 had longer total treatment duration (24±10 versus 14±5 months, P = .001). Eight (80%) group 1 and 9 (60%) group 2 patients achieved SVR. Mean grade and stage (modified Ishak score) were similar at 4 months, however, group 1 had higher grade (3±1.7 versus 1.6±1.3, P = .039) and stage (1.4±1.4 versus 0.5±0.6, P = .084) on the ISH assayed biopsy, after similar post LT intervals (23±10 versus 24±12 months, P = .91). Conclusion. Allograft HCV ISH nondetectability does not predict SVR in treatment responsive HCV recurrence, but is associated with less severe histologic disease.http://dx.doi.org/10.1155/2009/297528
spellingShingle M. Ghabril
R. C. Dickson
M. Krishna
R. Lloyd
J. Aranda-Michel
A. Keaveny
R. Satyanarayana
H. Bonatti
Persistence of Hepatitis C RNA in Liver Allografts Is Associated with Histologic Progression Independent of Serologic Viral Clearance
Journal of Transplantation
title Persistence of Hepatitis C RNA in Liver Allografts Is Associated with Histologic Progression Independent of Serologic Viral Clearance
title_full Persistence of Hepatitis C RNA in Liver Allografts Is Associated with Histologic Progression Independent of Serologic Viral Clearance
title_fullStr Persistence of Hepatitis C RNA in Liver Allografts Is Associated with Histologic Progression Independent of Serologic Viral Clearance
title_full_unstemmed Persistence of Hepatitis C RNA in Liver Allografts Is Associated with Histologic Progression Independent of Serologic Viral Clearance
title_short Persistence of Hepatitis C RNA in Liver Allografts Is Associated with Histologic Progression Independent of Serologic Viral Clearance
title_sort persistence of hepatitis c rna in liver allografts is associated with histologic progression independent of serologic viral clearance
url http://dx.doi.org/10.1155/2009/297528
work_keys_str_mv AT mghabril persistenceofhepatitiscrnainliverallograftsisassociatedwithhistologicprogressionindependentofserologicviralclearance
AT rcdickson persistenceofhepatitiscrnainliverallograftsisassociatedwithhistologicprogressionindependentofserologicviralclearance
AT mkrishna persistenceofhepatitiscrnainliverallograftsisassociatedwithhistologicprogressionindependentofserologicviralclearance
AT rlloyd persistenceofhepatitiscrnainliverallograftsisassociatedwithhistologicprogressionindependentofserologicviralclearance
AT jarandamichel persistenceofhepatitiscrnainliverallograftsisassociatedwithhistologicprogressionindependentofserologicviralclearance
AT akeaveny persistenceofhepatitiscrnainliverallograftsisassociatedwithhistologicprogressionindependentofserologicviralclearance
AT rsatyanarayana persistenceofhepatitiscrnainliverallograftsisassociatedwithhistologicprogressionindependentofserologicviralclearance
AT hbonatti persistenceofhepatitiscrnainliverallograftsisassociatedwithhistologicprogressionindependentofserologicviralclearance